Regulated genes by stimulation of chondrocytes with il-1.beta.

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 31/70 (2006.01) A61K 38/00 (2006.01) A61K 38/39 (2006.01) A61K 39/395 (2006.01) A61K 49/00 (2006.01) C07H 21/04 (2006.01) C12N 15/09 (2006.01) C12N 15/12 (2006.01) C12N 15/16 (2006.01) G01N 33/564 (2006.01) C07K 16/18 (2006.01)

Patent

CA 2159957

The present invention refers to the novel use of osteopontin, calnexin and TSG-6gene product in the diagnosis, prophylaxis or therapy of IL-1.beta. mediated diseases of connective tissues and to novel genes induced or repressed by stimulation of chondrocytes with IL-1.beta. and their use in the diagnosis, prophylaxis or therapy of IL- 1.beta. mediated diseases of connective tissues.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Regulated genes by stimulation of chondrocytes with il-1.beta. does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Regulated genes by stimulation of chondrocytes with il-1.beta., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated genes by stimulation of chondrocytes with il-1.beta. will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1483380

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.